col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


48 Ergebisse       Seite 1

 [1] 
Wiley: European Journal Of Haematology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Jan―06 SARS-COV-2 Pre-Exposure Prophylaxis With Tixagevimab-Cilgavimab in Haematological, Immunocompromised Patients in the Omicron Era Manuela A. Hoechstetter, Eva-Maria Hollwich, Doris Illner, Thu-Trang Pham, Michael von Bergwelt-Baildon, Martin Dreyling, Clemens-Martin Wendtner
2 [GO] 2024―Feb―05 Hybrid immunity to SARS-CoV-2 in patients with chronic lymphocytic leukemia Sibylle C. Mellinghoff, Sandra Robrecht, Rosanne Sprute, Leonie Mayer, Leonie M. Weskamm, Christine Dahlke, et al. (+14)
3 [GO] 2023―Dez―20 Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination Clement Twumasi, Sally Moore, Ross Sadler, Sally Jeans, Sherin Varghese, Alison Turner, et al. (+17)
4 [GO] 2023―Sep―23 Mortality and clinical outcomes following SARS-CoV-2 infection among individuals with haematological malignancies: A Danish population-based cohort study Lars Christian Lund, Martin Torp Rahbek, Peter Brown, Niels Obel, Jesper Hallas, Henrik Frederiksen
5 [GO] 2023―Aug―09 Efficacy of COVID-19 vaccination in adult patients with sickle cell disease: Comment Amnuay Kleebayoon, Viroj Wiwanitkit
6 [GO] 2023―Aug―09 Response to “Efficacy of COVID-19 vaccination in adult patients with sickle cell disease: Comment” Geoffrey Cheminet, Julien Derdevet, Jean-Benoît Arlet
7 [GO] 2023―Jul―31 Estrogen-based hormonal therapy and the risk of thrombosis in COVID-19 patients Corinne LaVasseur, Rick Mathews, Jenny S. H. Wang, Kylee Martens, Hannah Stowe McMurry, Shira Peress, et al. (+7)
8 [GO] 2023―Jul―26 Long-term clinical outcomes and healthcare utilization of sickle cell disease patients with COVID-19: A 2.5-year follow-up study Avery Feit, Moshe Gordon, Tharun T. Alamuri, Wei Hou, William B. Mitchell, Deepa Manwani, Tim Q. Duong
9 [GO] 2023―Jul―21 Demographics and outcomes of hemoglobin genotype in hospitalized patients with COVID-19 and sickle cell disease in the United States Nosakhare Paul Ilerhunmwuwa, Lawrence Inyang, Mustafa Wasifuddin, Henry Aiwuyo, Muhammad Tahir, Narek Hakobyan, et al. (+5)
10 [GO] 2023―Jul―18 Reduced prophylactic effect of tixagevimab-cilgavimab in patients with hematological malignancies and without antibody response after SARS-COV-2 vaccination Chiara Callegari, Davide Lazzarotto, Alessandra Soravia, Martina Mutti, Pietro Lauzzana, Maddalena Peghin, et al. (+3)
11 [GO] 2023―Jun―29 Efficacy of COVID-19 vaccination in adult patients with sickle cell disease during the Omicron wave in France Julien Derdevet, Brigitte Ranque, Djamal Khimoud, Laure Joseph, Adrien Michon, Edouard Flamarion, et al. (+5)
12 [GO] 2023―Jun―09 Outcomes of COVID-19 hospitalizations in patients with sickle cell disease: A nationwide analysis Nosakhare Paul Ilerhunmwuwa, Lawrence Inyang, Narek Hakobyan, Mustafa Wasifuddin, Muhammad Tahir, Henry Aiwuyo, et al. (+4)
13 [GO] 2023―Mrz―25 Trajectories of the SARS-CoV -2 RNA load in patients with haematological malignancy Satoshi Mitsuyuki, Masashi Nishikubo, Yoshimitsu Shimomura, Yukie Ohyama, Hayato Maruoka, Seiko Nasu, et al. (+16)
14 [GO] 2023―Jan―19 Global reported impacts of COVID -19 on lymphoma patients and the emerging clinical management approaches in response to the ongoing pandemic. Esther K. Elliott, Robert Hensen, Larisa M. Haupt, Lyn R. Griffiths
15 [GO] 2022―Nov―02 Outcomes of coronavirus disease 2019 ( COVID -19) and risk factors associated with severe COVID -19 in patients with mature B-cell non-Hodgkin lymphomas: a US electronic health record cohort study Xiaomeng Yue, David Hallett, Yangyang Liu, Elisa Basa, Annie McNeill, James P. Dean
16 [GO] 2022―Okt―04 Incidence of Symptomatic Covid-19 Infections in Patients with Mastocytosis and Chronic Myeloid Leukemia: a Comparison with the General Austrian Population Irene Graf, Susanne Herndlhofer, Michael Kundi, Georg Greiner, Martina Sperr, Emir Hadzijusufovic, et al. (+2)
17 [GO] 2022―Aug―28 COVID-19: Vaccine-induced immune thrombotic thrombocytopenia (VITT) Fazal-i-Akbar Danis, Ahmad Ehsan Rabani, Fazal-e-Rabi Subhani, Saeeda Yasmin, Salman Shafi Koul
18 [GO] 2022―Jul―10 Neutralizing antibody responses against SARS-CoV-2 in patients with plasma cell disorders who are on active treatment after two doses of mRNA vaccination Al-Ola Abdallah, Zahra Mahmoudjafari, Tahani Atieh, Nausheen Ahmed, Wei Cui, Leyla Shune, et al. (+7)
19 [GO] 2022―Jun―25 Early report on the severity of COVID-19 in hematologic patients infected with the SARS-CoV2 omicron variant Fabian Ullrich, Christine Hanoun, Amin T. Turki, Tobias Liebregts, Katharina Breuckmann, Ferras Alashkar, et al. (+3)
20 [GO] 2022―Mai―20 Acquired Aplastic Anemia following SARS-CoV-2 Vaccination Alexander Röth, Stefanie Bertram, Thomas Schroeder, Thomas Haverkamp, Sebastian Voigt, Caroline Holtkamp, et al. (+4)
21 [GO] 2022―Feb―17 Antibody titers after SARS-CoV-2 mRNA vaccination in patients with aplastic anemia - a single center study Jeanette Walter, Kim Kricheldorf, Susanne Isfort, Tim H. Brümmendorf, Jens Panse, Fabian Beier
22 [GO] 2021―Dez―18 Evaluation of Soluble Fibrin Monomer Complex in Patients in SARS-CoV-2 COVID-19 Infection Associated Coagulopathy Meera Sridharan, Serena Navitskas, Elizabeth Kock, Damon Houghton, Nahla M Heikal, Dong Chen, Rajiv Pruthi
23 [GO] 2021―Dez―02 mRNA COVID-19 vaccines in patients with CLL: A systematic review and meta-analysis Stefano Molica, Diana Giannarelli, Emili Montserrat
24 [GO] 2021―Okt―30 Reasons and consequences of COVID-19 vaccine failure in patients with chronic lymphocytic leukemia Marta Morawska
25 [GO] 2021―Sep―30 Relapse of immune thrombocytopenia after COVID-19 vaccination Wobke E. M. van Dijk, Roger E. G. Schutgens
26 [GO] 2021―Mai―14 COVID-19 Vaccine-associated Immune Thrombosis and Thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome Massimo Franchini, Giancarlo Maria Liumbruno, Mario Pezzo
27 [GO] 2021―Apr―29 White Blood Count, D-dimers and Ferritin levels as Predictive Factors of Pulmonary Embolism suspected upon admission in noncritically ill COVID-19 patients: the French multicenter CLOTVID retrospective study J Galland, B Thoreau, M Delrue, M Neuwirth, A Stepanian, A Chauvin, et al. (+110)
28 [GO] 2021―Mrz―29 Clinical Predictors Of SARS-CoV-2 Neutralizing Antibody Titers In COVID-19 Convalescents: Implications For Convalescent Plasma Donor Recruitment Daniele Focosi, Massimo Franchini
29 [GO] 2021―Feb―20 Long-term follow up of patients with venous thromboembolism and COVID-19: analysis of risk factors for death and major bleeding Pablo Demelo-Rodríguez, Lucía Ordieres-Ortega, Zichen Ji, Jorge del Toro-Cervera, Javier de Miguel-Díez, Luis Antonio Álvarez-Sala-Walther, Francisco Galeano-Valle
30 [GO] 2021―Jan―27 Internet based patient survey on the consequences of COVID-19 lockdown on treatment and medical follow-up of patients with aplastic anemia or paroxysmal nocturnal hemoglobinuria in Germany Fabian Beier, Kim Kricheldorf, Pascale Burmester, Ulrike Göbel, Susanne Isfort, Jens Panse, Tim H Brümmendorf
31 [GO] 2020―Nov―16 The impact of COVID-19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single center experience Holly Lee, Jason Tay, Peter Duggan, Sylvia McCulloch, Paola Neri, Nizar J Bahlis, Victor H Jimenez-Zepeda
32 [GO] 2020―Okt―12 Association of Anticoagulation Dose and Survival in Hospitalized COVID-19 Patients: A Retrospective Propensity Score Weighted Analysis Filip Ionescu, Ishmael Jaiyesimi, Ioana Petrescu, Patrick R Lawler, Edward Castillo, Yolanda Munoz-Maldonado, et al. (+5)
33 [GO] 2020―Sep―26 Transfusion requirements in patients with COVID-19 A.P. Worrall, C. Kelly, A. O’Neill, N Reidy, M. O’Doherty, L Griffin, et al. (+11)
34 [GO] 2020―Sep―17 SARS-CoV-2 infection among patients with haematological disorders: Severity and one-month outcome in 66 Danish patients in a nationwide cohort study Andreas Glenthøj, Lasse H Jakobsen, Henrik Sengeløv, Syed A Ahmad, Kristian Qvist, Annika Rewes, et al. (+18)
35 [GO] 2020―Aug―14 Characteristics of peripheral blood differential counts in hospitalized patients with COVID-19 Irene Pakos, Kevin Bryan Lo, Grace Salacup, Jerald Pelayo, Ruchika Bhargav, Eric Peterson, et al. (+6)
36 [GO] 2020―Aug―04 COVID-19 coagulopathy: an in-depth analysis of the coagulation system Reyes María Martín-Rojas, Gloria Pérez-Rus, Valeria Estefania Delgado-Pinos, Amalia Domingo-González, Isabel Regalado-Artamendi, Natalia Alba-Urdiales, et al. (+7)
37 [GO] 2020―Aug―03 Outcome of COVID-19 in multiple myeloma patients in relation to treatment Katharina Helene Susek, Charlotte Gran, Hans-Gustaf Ljunggren, Evren Alici, Hareth Nahi
38 [GO] 2020―Jul―25 Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies José María Sanchez-Pina, Mario Rodríguez Rodriguez, Nerea Castro Quismondo, Rodrigo Gil Manso, Rafael Colmenares, Daniel Gil Alos, et al. (+20)
39 [GO] 2020―Jul―14 Hematolological Manifestations of COVID-19: From Cytopenia to Coagulopathy Charles Agbuduwe, Supratik Basu
40 [GO] 2020―Jun―27 Favorable COVID-19 course despite significant comorbidities in a ruxolitinib-treated patient with primary myelofibrosis Steffen Koschmieder, Edgar Jost, Christian Cornelissen, Tobias Müller, Maximilian Schulze-Hagen, Johannes Bickenbach, et al. (+5)
41 [GO] 2020―Jun―27 Sickle Cell Trait and The Potential Risk of Severe Coronavirus Disease 2019- A Mini-Review Tawakalitu Abosede Kehinde, Mayowa Azeez Osundiji
42 [GO] 2020―Jun―27 Myeloma care adaptations in the UK during SARS-CoV-2 pandemic: challenges and measurable outcomes Faouzi Djebbari, Fotios Panitsas, Faye A. Sharpley, Alexandros Rampotas, Jemma Larham, Sally Moore, et al. (+3)
43 [GO] 2020―Jun―23 COVID-19 and thalassaemia: A position statement of the Thalassaemia International Federation Dimitrios Farmakis, Anastasios Giakoumis, Lily Cannon, Michael Angastiniotis, Androulla Eleftheriou
44 [GO] 2020―Jun―23 COVID-19 complicated by parainfluenza co-infection in a patient with chronic lymphocytic leukemia Petra Langerbeins, Moritz Fürstenau, Henning Gruell, Florian Klein, Thorsten Persigehl, Jan Rybniker, et al. (+6)
45 [GO] 2020―Jun―17 Janus faced course of COVID-19 infection in patients with hematological malignancies Rosa Bellmann-Weiler, Francesco Burkert, Theresa Schwaiger, Stephan Schmidt, Christof Ludescher, Horst Oexle, et al. (+2)
46 [GO] 2020―Jun―16 Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy Stephen Booth, John Willan, Henna Wong, Dalia Khan, Rachel Farnell, Alicia Hunter, et al. (+14)
47 [GO] 2020―Jun―05 Doubtful precipitation of hemolysis by hydroxychloroquine in glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection T.P Afra, Ram Vasudevan Nampoothiri, Muhammed Razmi T
48 [GO] 2020―Apr―23 COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency Yan Beauverd, Yannick Adam, Benjamin Assouline, Kaveh Samii
 [1] 

48 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.007 sec